{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-221971","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2026-05-13T21:20:45+00:00","discovered_at":"2026-05-13T21:22:00.351511+00:00","generated_at":"2026-05-13T21:30:19.136909+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"vTv Therapeutics upsizes ATM program to maximum authorized shares","bullets":["Filed a prospectus supplement to increase shares offered under its at-the-market sales program to the full amount authorized.","The expanded ATM program is under the company's existing shelf registration statement on Form S-3.","Legal opinion from Dechert LLP on share legality was filed as part of the registration update."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-221971","json":"https://secwatch.observer/filing/0001193125-26-221971.json","markdown":"https://secwatch.observer/filing/0001193125-26-221971.md","text":"https://secwatch.observer/filing/0001193125-26-221971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/0001193125-26-221971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000119312526221971/d72453d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T21:30:19.136909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}